Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Investigation on Quantitative Structure-Activity Relationships of 1,3,4-Oxadiazole Derivatives as Potential Telomerase Inhibitors

Author(s): Marco Tutone*, Beatrice Pecoraro and Anna M. Almerico

Volume 17, Issue 1, 2020

Page: [79 - 86] Pages: 8

DOI: 10.2174/1570163815666180724113208

Price: $65

Abstract

Background: Telomerase, a reverse transcriptase, maintains telomere and chromosomes integrity of dividing cells, while it is inactivated in most somatic cells. In tumor cells, telomerase is highly activated, and works in order to maintain the length of telomeres causing immortality, hence it could be considered as a potential marker to tumorigenesis.A series of 1,3,4-oxadiazole derivatives showed significant broad-spectrum anticancer activity against different cell lines, and demonstrated telomerase inhibition.

Methods: This series of 24 N-benzylidene-2-((5-(pyridine-4-yl)-1,3,4-oxadiazol-2yl)thio)acetohydrazide derivatives as telomerase inhibitors has been considered to carry out QSAR studies. The endpoint to build QSAR models is determined by the IC50 values for telomerase inhibition, i.e., the concentration (μM) of inhibitor that produces 50% inhibition. These values were converted to pIC50 (- log IC50) values. We used the most common and transparent method, where models are described by clearly expressed mathematical equations: Multiple Linear Regression (MLR) by Ordinary Least Squares (OLS).

Results: Validated models with high correlation coefficients were developed. The Multiple Linear Regression (MLR) models, by Ordinary Least Squares (OLS), showed good robustness and predictive capability, according to the Multi-Criteria Decision Making (MCDM = 0.8352), a technique that simultaneously enhances the performances of a certain number of criteria. The descriptors selected for the models, such as electrotopological state (E-state) descriptors, and extended topochemical atom (ETA) descriptors, showed the relevant chemical information contributing to the activity of these compounds.

Conclusion: The results obtained in this study make sure about the identification of potential hits as prospective telomerase inhibitors.

Keywords: 1, 3, 4-oxadiazoles, anticancer activity, Telomerase inhibitors, QSAR, 2D descriptors, MLR.

Graphical Abstract

[1]
Wright WE, Shay JW. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 2000; 6(8): 849-51.
[http://dx.doi.org/10.1038/78592] [PMID: 10932210]
[2]
Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295(5564): 2446-9.
[http://dx.doi.org/10.1126/science.1069523] [PMID: 11923537]
[3]
Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279(5349): 349-52.
[http://dx.doi.org/10.1126/science.279.5349.349] [PMID: 9454332]
[4]
Gillis AJ, Schuller AP, Skordalakes E. Structure of the Tribolium castaneum telomerase catalytic subunit TERT. Nature 2008; 455(7213): 633-7.
[http://dx.doi.org/10.1038/nature07283] [PMID: 18758444]
[5]
Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33(5): 787-91.
[http://dx.doi.org/10.1016/S0959-8049(97)00062-2] [PMID: 9282118]
[6]
Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92(20): 9082-6.
[http://dx.doi.org/10.1073/pnas.92.20.9082] [PMID: 7568077]
[7]
Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266(5193): 2011-5.
[http://dx.doi.org/10.1126/science.7605428] [PMID: 7605428]
[8]
Steczkiewicz K, Zimmermann MT, Kurcinski M, et al. Human telomerase model shows the role of the TEN domain in advancing the double helix for the next polymerization step. Proc Natl Acad Sci USA 2011; 108(23): 9443-8.
[http://dx.doi.org/10.1073/pnas.1015399108] [PMID: 21606328]
[9]
Autexier C, Lue NF. The structure and function of telomerase reverse transcriptase. Annu Rev Biochem 2006; 75: 493-517.
[http://dx.doi.org/10.1146/annurev.biochem.75.103004.142412] [PMID: 16756500]
[10]
Herbert B, Pitts AE, Baker SI, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 1999; 96(25): 14276-81.
[http://dx.doi.org/10.1073/pnas.96.25.14276] [PMID: 10588696]
[11]
Sun D, Thompson B, Cathers BE, et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 1997; 40(14): 2113-6.
[http://dx.doi.org/10.1021/jm970199z] [PMID: 9216827]
[12]
Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996; 16(1): 53-65.
[http://dx.doi.org/10.1128/MCB.16.1.53] [PMID: 8524329]
[13]
Lauria A, Terenzi A, Bartolotta R, et al. Does ligand symmetry play a role in the stabilization of DNA G-quadruplex host-guest complexes? Curr Med Chem 2014; 21(23): 2665-90.
[http://dx.doi.org/10.2174/0929867321666140217155156] [PMID: 24533802]
[14]
Paul A, Maji B, Misra SK, Jain AK, Muniyappa K, Bhattacharya S. Stabilization and structural alteration of the G-quadruplex DNA made from the human telomeric repeat mediated by Tröger’s base based novel benzimidazole derivatives. J Med Chem 2012; 55(17): 7460-71.
[http://dx.doi.org/10.1021/jm300442r] [PMID: 22827615]
[15]
El-sayed WA, El-essawy FA, Ali OM, Nasr BS. Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues. Z Natforsch C J Biosci 2009; 64(11-12): 773-8.
[16]
Abadi AH, Eissa AAH, Hassan GS. Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem Pharm Bull (Tokyo) 2003; 51(7): 838-44.
[http://dx.doi.org/10.1248/cpb.51.838] [PMID: 12843591]
[17]
Szczepankiewicz BG, bruce g, Chiou WJ, et al. New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models. J Med Chem 2001; 44(25): 4416-30.
[18]
Zheng QZ, Zhang XM, Xu Y, Cheng K, Jiao QC, Zhu HL. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents. Bioorg Med Chem 2010; 18(22): 7836-41.
[http://dx.doi.org/10.1016/j.bmc.2010.09.051] [PMID: 20947362]
[19]
Zhang XM, Qiu M, Sun J, et al. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Bioorg Med Chem 2011; 19(21): 6518-24.
[http://dx.doi.org/10.1016/j.bmc.2011.08.013] [PMID: 21962523]
[20]
Linder J, Garner TP, Williams HEL, Searle MS, Moody CJ. Telomestatin: formal total synthesis and cation-mediated interaction of its seco-derivatives with G-quadruplexes. J Am Chem Soc 2011; 133(4): 1044-51.
[http://dx.doi.org/10.1021/ja109158k] [PMID: 21162526]
[21]
Wang Y, Cheng FX, Yuan XL, et al. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Eur J Med Chem 2016; 112: 231-51.
[http://dx.doi.org/10.1016/j.ejmech.2016.02.009] [PMID: 26900656]
[22]
Xiao X, Ni Y, Jia YM, et al. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects. Bioorg Med Chem Lett 2016; 26(6): 1508-11.
[http://dx.doi.org/10.1016/j.bmcl.2016.02.025] [PMID: 26883149]
[23]
Zhang H-J, Qian Y, Zhu D-D, Yang X-G, Zhu H-L. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. Eur J Med Chem 2011; 46(9): 4702-8.
[http://dx.doi.org/10.1016/j.ejmech.2011.07.016] [PMID: 21816517]
[24]
Kubinyi H. QSAR and 3D QSAR in drug design part 2: Applications and problems. Drug Discov Today 1997; 2(12): 538-46.
[http://dx.doi.org/10.1016/S1359-6446(97)01084-2]
[25]
Almerico A, Tutone M, Ippolito M, Lauria A. Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors. Curr Comput Aided-Drug Des 2007; 3(3): 214-33.
[http://dx.doi.org/10.2174/157340907781695468]
[26]
Almerico AM, Tutone M, Lauria A. A QSAR study investigating the potential anti-HIV-1 effect of some Acyclovir and Ganciclovir analogs. Issue in Honor of Prof Nicolò Vivona. ARKIVOC 2009; 8: 85-94.
[27]
Gramatica P. Principles of QSAR models validation: Internal and external. QSAR Comb Sci 2007; 26(5): 694-701.
[http://dx.doi.org/10.1002/qsar.200610151]
[28]
Pibiri I, Lentini L, Tutone M, Melfi R, Pace A, Di Leonardo A. Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening. Eur J Med Chem 2016; 122: 429-35.
[http://dx.doi.org/10.1016/j.ejmech.2016.06.048] [PMID: 27404557]
[29]
Boström J, Hogner A, Llinàs A, Wellner E, Plowright AT. Oxadiazoles in medicinal chemistry. J Med Chem 2012; 55(5): 1817-30.
[http://dx.doi.org/10.1021/jm2013248] [PMID: 22185670]
[30]
Zhang F, Wang X-L, Shi J, et al. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents. Bioorg Med Chem 2014; 22(1): 468-77.
[http://dx.doi.org/10.1016/j.bmc.2013.11.004] [PMID: 24286761]
[31]
Lauria A, Tutone M, Almerico AM. Virtual lock-and-key approach: the in silico revival of Fischer model by means of molecular descriptors. Eur J Med Chem 2011; 46(9): 4274-80.
[http://dx.doi.org/10.1016/j.ejmech.2011.06.033] [PMID: 21775029]
[32]
Tutone M, Perricone U, Almerico AM. Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach. J Mol Graph Model 2017; 71: 50-7.
[http://dx.doi.org/10.1016/j.jmgm.2016.11.006] [PMID: 27842227]
[33]
Yap CW. PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 2011; 32(7): 1466-74.
[http://dx.doi.org/10.1002/jcc.21707] [PMID: 21425294]
[34]
Chirico N, Gramatica P. Real external predictivity of QSAR models. Part 2. New intercomparable thresholds for different validation criteria and the need for scatter plot inspection. J Chem Inf Model 2012; 52(8): 2044-58.
[http://dx.doi.org/10.1021/ci300084j] [PMID: 22721530]
[35]
Shi LM, Fang H, Tong W, et al. QSAR models using a large diverse set of estrogens. J Chem Inf Comput Sci 2001; 41(1): 186-95.
[http://dx.doi.org/10.1021/ci000066d] [PMID: 11206373]
[36]
Schüürmann G, Ebert RU, Chen J, Wang B, Kühne R. External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs training set activity mean. J Chem Inf Model 2008; 48(11): 2140-5.
[http://dx.doi.org/10.1021/ci800253u] [PMID: 18954136]
[37]
Consonni V, Ballabio D, Todeschini R. Comments on the definition of the Q2 parameter for QSAR validation. J Chem Inf Model 2009; 49(7): 1669-78.
[http://dx.doi.org/10.1021/ci900115y] [PMID: 19527034]
[38]
Golbraikh A, Tropsha A. Beware of q2! J Mol Graph Model 2002; 20(4): 269-76.
[http://dx.doi.org/10.1016/S1093-3263(01)00123-1] [PMID: 11858635]
[39]
Ojha PK, Mitra I. Das RN, Roy K. Further exploring rm2 metrics for validation of QSPR models. Chemom Intell Lab Syst. Elsevier BV 2011; 107(1): 194-205.
[40]
Lin LI. A Concordance Correlation Coefficient to Evaluate Reproducibility Author (s): Lawrence I-Kuei Lin Published by : International Biometric Society Stable http://www.jstor.org/stable/25320512016
[41]
Keller HR, Massart DL, Brans JP. Multicriteria decision making: A case study. Chemom Intell Lab Syst 1991; 11(2): 175-89.
[http://dx.doi.org/10.1016/0169-7439(91)80064-W]
[42]
Bhhatarai B, Teetz W, Liu T, et al. CADASTER QSPR Models for predictions of melting and boiling points of perfluorinated chemicals. Mol Inform 2011; 30(2-3): 189-204.
[http://dx.doi.org/10.1002/minf.201000133] [PMID: 27466773]
[43]
Nandi S, Bagchi MC. Importance of Kier-Hall topological indices in the QSAR of anticancer drug design. Curr Comput Aided Drug Des 2012; 8(2): 159-70.
[http://dx.doi.org/10.2174/157340912800492384] [PMID: 22497470]
[44]
Todeschini R, Consonni V. Molecular Descriptors for Chemoinformatics. In: Recent Advances in QSAR Studies. 2010; pp. 29-103.
[45]
Gramatica P, Chirico N, Papa E, Cassani S, Kovarich S. QSARINS: A new software for the development, analysis, and validation of QSAR MLR models. J Comput Chem 2013; 34(24): 2121-32.
[http://dx.doi.org/10.1002/jcc.23361]

Rights & Permissions Print Cite
Article Metrics
15
2
© 2024 Bentham Science Publishers | Privacy Policy